The DRIVE-AB project is part of the IMI’s New Drug For Bad Bugs (ND4BB) initiative
The new European AMR plan relies on the “One Health” approach
The Office of Health Economic (UK) has released a report that assess the relevance
Mutabilis will be represented at the European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) in Vienne from April 22nd to 25th 2017.
Mutabilis will be rerpesented at the “Superdrugs for Superbugs” conference in London on March 20th and 21st 2017.
The Organization has published its first list of the 12 most worrying pathogens
Mutabilis will be at the Gordon Research Conferences in Italy.
Conference on Retrovirus and Opportunistic Infections.
Three new patents delivered on the anti-HIV project
The UK Review on Anti-Microbial Resistance headed by Jim O’Neil